Clinicians Challenge Andropause Marketing and Outline Proper Male Hormone Testing Rules
On September 12, 2026, Le Journal de Montréal published an opinion article arguing that so-called andropause is principally a marketing term used to sell testosterone supplements rather than a direct male equivalent of menopause. This medical critique challenges the popular assumption that aging men undergo a single predictable hormonal event.
Analyzing Hormone Decline
To understand why comparing male aging to menopause falls short, we must examine how clinical frameworks measure physical changes. The European Male Ageing Study framework proposed a specific diagnostic approach for identifying late-onset hypogonadism. Researchers recommended evaluating specific patient experiences alongside verified blood test thresholds. This targeted framework aims to separate medically significant decline from normal aging.
Under this framework, clinicians look for three core sexual symptoms to form a diagnosis. They measure these symptoms alongside blood thresholds defined as total testosterone below 11 nmol/L and free testosterone below 220 pmol/L. This methodology prevents doctors from diagnosing a major endocrine condition based solely on generalized fatigue. Proper hormones and vitality assessments require consistent laboratory confirmation over multiple sessions.
Explicit Clinical Indicators
The clinical analysis indicates that symptoms frequently associated with andropause are highly nonspecific. Low energy, reduced strength, depressed mood, and sleep problems do not automatically prove a hormonal deficiency. A low testosterone measurement alone is not sufficient to establish clinically significant hypogonadism under current clinical guidance. Symptoms and signs must be considered alongside consistently low laboratory values to form a complete clinical picture.
The European Male Ageing Study framework highlights that specific sexual symptoms have a much closer relationship with true testosterone deficiency. Reduced libido, fewer morning erections, and erectile dysfunction are far stronger clinical indicators than nonspecific fatigue alone. When these persistent signs align with verified low test results, a structured medical evaluation is highly appropriate. Ignoring these specific steps can lead men to chase incorrect treatments.
Morning Testing Requirements
Testosterone concentrations vary significantly during the day, making testing timing critical. Hormone levels must be measured in the morning to capture an accurate baseline. A single test can be highly misleading without a repeat morning measurement to confirm the initial low result. Patients should always verify that an abnormal result will be repeated before any treatment begins.
If a deficiency is confirmed, patients must discuss several health variables with a qualified clinician. These variables include prostate health, hematocrit levels, cardiovascular risk, and sleep apnea status. Men must also consider fertility implications before starting treatment. This structured evaluation ensures that therapy is applied safely and effectively rather than as a generalized anti-aging tool.
Overlapping Health Factors
Symptoms frequently linked to the andropause concept can have several possible causes entirely outside of the male endocrine system. Clinical literature specifically identifies chronic disease, obesity, and sleep apnea as relevant considerations in testosterone assessment. Men managing their energy and body composition must look beyond a single hormone marker. Inadequate recovery and psychological stress also mimic the symptoms often blamed on age-related hormone loss.
Tiredness and a changing waistline should never be treated as absolute proof of low testosterone. Doctors recommend investigating medication effects, daily stress levels, and overall metabolic health first. Older men can support their physical capability through consistent strength and physical performance routines. Addressing these lifestyle factors often resolves the nonspecific symptoms associated with the andropause label.
Structural Limitations and Context
The claim that andropause is mostly a marketing invention comes directly from the Le Journal de Montréal opinion article. This deliberately sharp framing highlights the commercial interests behind over-the-counter testosterone supplements. The term can mislead readers by suggesting that every aging man will experience a uniform hormonal crash.
However, rejecting the andropause label does not mean that age-related testosterone decline is imaginary. The medical comparison simply remains limited because menopause is a relatively well-defined reproductive transition. In contrast, age-related testosterone reduction in older men is typically gradual and highly variable. This critical evaluation of the andropause concept confirms existing clinical knowledge by reinforcing that testosterone decline is a complex process requiring rigorous, symptom-led laboratory confirmation rather than a universal assumption of aging.
How Everfitguys helps
Deciding whether to attribute age-related physical changes to an inevitable hormonal crash requires structured medical evaluation rather than relying on oversimplified marketing labels, and Everfitguys interprets current endocrinology research to help you navigate this complex process. Falling energy, slower metabolism and unwanted changes in body composition frequently drive men toward these hasty diagnostic conclusions, so Everfitguys translates clinical data to help you target the actual physiological factors controlling your health.
Sources
Stay sharp
Get stories
The best writing on craft and life, delivered once a week. No noise, just the good stuff.
